Avadel Pharmaceuticals PLC (NASDAQ:AVDL)

7.71
Delayed Data
As of Feb 20
 -0.03 / -0.39%
Today’s Change
7.52
Today|||52-Week Range
12.30
-5.98%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2013

2014

2015

2016
Operating ActivitiesNet Income / Starting Line-43.0M-83.6M40.4M-41.2M
 
 
 
 
 
Depreciation3.1M13.9M13.1M14.4M
 
 
 
 
 
Total Other Cash Flow30.2M43.3M33.7M70.9M
 
 
 
 
 
Funds From Operations-21.0M-29.1M88.6M40.2M
 
 
 
 
 
Funds From/For Other Operating Expenses-280.2K-18.7M4.8M21.3M
 
 
 
 
 
Net Cash Flow - Operating Activities-20.7M-10.5M83.8M18.8M
 
 
 
 
 
 
InvestingIncrease In Investments-1.1M-67.2M-50.3M-107.3M
 
 
 
 
 
Decrease In Investments7.2M13.5M20.4M71.3M
 
 
 
 
 
Capital Expenditures-1.0M-1.7M-1.6M-1.2M
 
 
 
 
 
Fixed Asset Disposal1.0M13.0M0.00626.2K
 
 
 
 
Net Cash Flow Investing6.0M-42.4M-31.6M-36.5M
 
 
 
 
 
 
FinancingShort Term Borrowings----------
Long Term Borrowings19.3M0.000.000.00
 
 
Long Term Debt Reduction-552.4K-34.4M-9.0M-1.5M
 
 
 
 
 
Net Proceeds Stock Sale400.3K130.2M7.0M438.7K
 
 
 
 
 
Common Preferred Redeemed0.000.000.000.00--
Common Dividends0.000.000.000.00--
Cash Dividends Paid - Total0.000.000.000.00--
Other Sources - Financing0.000.002.8M0.00
 
 
Other Uses - Financing907.6K1.3M24.4M6.9M
 
 
 
 
 
Net Cash Flow - Financing18.3M94.5M-23.6M-7.9M
 
 
 
 
 
 
Exchange RateEffect of Exchange Rate on Cash252.2K-9.0M-3.5M-165.5K
 
 
 
 
 
 
Net Change In Cash3.6M41.7M28.7M-25.6M